ClinicalTrials.govpublic full text
Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
nonalcoholic steatohepatitis, nonalcoholic fatty liver disease
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 121313 · SHA-256 e5bfa50054351e7a
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.